FOS and metabolic dysfunction-associated steatohepatitis: Therefore, RA can be reasonably concluded to reduce TLR4 expression and activation, thereby decreasing the phosphorylation of its downstream molecules, exhibiting an inhibitory effect on AP1 translocation, reducing inflammation, and alleviating NASH.